UNSPSC 51283109: Micafungin sodium

This classification denotes an antifungal agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier IS1UP79R56. European Medicines Agency schedules Micafungin sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20666. Micafungin sodium generally arises in the molecular formula C56H70N9O23S.NA. The term 'micafungin sodium' is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule micafungin sodium under HS 29419000 and SITC 54139.

UNSPSC 51283109 Micafungin sodium is a Commodity code, but the recent state and local opportunities posted under it show a mismatch with the code's pharmaceutical-specific scope. The four recent solicitations tracked under this code involve naloxone and drug deactivation systems (Seminole County, Florida), direct-to-manufacturer prescription programs (Texas HHS Commission), emergency medical and first aid supplies for fire rescue operations (City of Tampa), and generic multi-source pharmaceuticals and OTC products through a cooperative purchasing vehicle (Minnesota Multistate Cooperative Purchasing Alliance). Only the MMCAP opportunity involves pharmaceuticals in the conventional sense; the others—naloxone, emergency medical supplies, and prescription program infrastructure—do not align with micafungin sodium, an antifungal medication used in hospital and clinical settings. The code shows little relevant recent activity for the actual commodity it nominally describes.

The issuing-body mix spans state health and human services agencies (Texas HHS Commission), state procurement offices administering cooperative purchasing (Minnesota Department of Administration), county health departments (Seminole County), and city fire departments (City of Tampa). Geographic activity touches Florida, Texas, and Minnesota, with the MMCAP cooperative extending to Oregon. Representative opportunities include Seminole County's IFB for naloxone and drug deactivation systems due July 26, 2023 (posted June 30, 2026, with a noted date inconsistency in the source), City of Tampa's IFB for medical and first aid supplies due March 13, 2026 with an estimated contract value of $700,000 and a sheltered small local business enterprise set-aside, and Minnesota's MMCAP RFP for generic pharmaceuticals and OTC products due March 26, 2026 across three authorized wholesalers. The code's recent posting history does not support reliable pursuit activity in the micafungin sodium category itself.